Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death

[1]  J. Highley,et al.  ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles , 2019, Acta Neuropathologica Communications.

[2]  C. Shaw,et al.  ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS , 2018, Neuron.

[3]  J. C. Baayen,et al.  Increased expression of matrix metalloproteinase 3 can be attenuated by inhibition of microRNA-155 in cultured human astrocytes , 2018, Journal of Neuroinflammation.

[4]  T. Boeckers,et al.  NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS , 2018, The EMBO journal.

[5]  G. Sobue,et al.  Importance of Functional Loss of FUS in FTLD/ALS , 2018, Front. Mol. Biosci..

[6]  K. Krishnamurthy,et al.  Astrocytes expressing ALS‐linked mutant FUS induce motor neuron death through release of tumor necrosis factor‐alpha , 2018, Glia.

[7]  B. Burke,et al.  Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in ‘FUSDelta14’ knockin mice , 2017, Brain : a journal of neurology.

[8]  S. Cavallaro,et al.  Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets , 2017, Mediators of inflammation.

[9]  C. Moriconi,et al.  Neuroserpin polymers cause oxidative stress in a neuronal model of the dementia FENIB , 2017, Neurobiology of Disease.

[10]  D. Dormann,et al.  TDP‐43 and FUS en route from the nucleus to the cytoplasm , 2017, FEBS letters.

[11]  E. Cacci,et al.  Transcriptional response of Hoxb genes to retinoid signalling is regionally restricted along the neural tube rostrocaudal axis , 2017, Royal Society Open Science.

[12]  Alessio Colantoni,et al.  FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons , 2017, Nature Communications.

[13]  E. Cacci,et al.  Histone Methylation and microRNA-dependent Regulation of Epigenetic Activities in Neural Progenitor Self-Renewal and Differentiation. , 2017, Current topics in medicinal chemistry.

[14]  D. Zang,et al.  Evaluating the levels of CSF and serum factors in ALS , 2017, Brain and behavior.

[15]  D. Gómez-Almaguer,et al.  Altered CSF cytokine network in amyotrophic lateral sclerosis patients: A pathway‐based statistical analysis , 2017, Cytokine.

[16]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[17]  P. Popoli,et al.  Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis , 2016, Neurotherapeutics.

[18]  F. Guillemot,et al.  Erratum to: Preservation of positional identity in fetus-derived neural stem (NS) cells from different mouse central nervous system compartments , 2016, Cellular and Molecular Life Sciences.

[19]  Ana P. Teixeira,et al.  Functional and phenotypic differences of pure populations of stem cell‐derived astrocytes and neuronal precursor cells , 2016, Glia.

[20]  Xiang-Dong Fu,et al.  Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss , 2016, The EMBO journal.

[21]  J. Tapia,et al.  ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function , 2016, Nature Communications.

[22]  Chuen-Mao Yang,et al.  NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review , 2015, Front. Mol. Neurosci..

[23]  H. Gendelman,et al.  A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders , 2015, Journal of Neuroimmune Pharmacology.

[24]  L. Stanton,et al.  RE1 silencing transcription factor/neuron‐restrictive silencing factor regulates expansion of adult mouse subventricular zone‐derived neural stem/progenitor cells in vitro , 2015, Journal of neuroscience research.

[25]  S. Appel,et al.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis , 2015, Neurotherapeutics.

[26]  Lisle W. Blackbourn,et al.  Human-derived neural progenitors functionally replace astrocytes in adult mice. , 2015, The Journal of clinical investigation.

[27]  S. McKnight,et al.  Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells , 2014, Science.

[28]  I. Bozzoni,et al.  Mir-23a and mir-125b regulate neural stem/progenitor cell proliferation by targeting Musashi1 , 2014, RNA biology.

[29]  K. Eggan,et al.  Genetic validation of a therapeutic target in a mouse model of ALS , 2014, Science Translational Medicine.

[30]  I. Bozzoni,et al.  An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA–FUS regulatory circuitry , 2014, Nature Communications.

[31]  Sunhee C. Lee,et al.  LPS and IL‐1 differentially activate mouse and human astrocytes: Role of CD14 , 2014, Glia.

[32]  D. Brites,et al.  Microglia centered pathogenesis in ALS: insights in cell interconnectivity , 2014, Front. Cell. Neurosci..

[33]  P. Popovich,et al.  Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis , 2014, Neuron.

[34]  Adriano Chiò,et al.  State of play in amyotrophic lateral sclerosis genetics , 2013, Nature Neuroscience.

[35]  P. Rossini,et al.  Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. , 2013, Human molecular genetics.

[36]  R. Simone,et al.  Microglial polarization and plasticity: Evidence from organotypic hippocampal slice cultures , 2013, Glia.

[37]  O. Paulsen,et al.  Stem Cells Expanded from the Human Embryonic Hindbrain Stably Retain Regional Specification and High Neurogenic Potency , 2013, The Journal of Neuroscience.

[38]  Xiong-hao Liu,et al.  Expression of ALS‐linked TDP‐43 mutant in astrocytes causes non‐cell‐autonomous motor neuron death in rats , 2013, The EMBO journal.

[39]  M. A. Ajmone-Cat,et al.  Branched-chain amino acids influence the immune properties of microglial cells and their responsiveness to pro-inflammatory signals. , 2013, Biochimica et biophysica acta.

[40]  E. Cacci,et al.  The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms. , 2013, Stem cells and development.

[41]  I. Bozzoni,et al.  FUS stimulates microRNA biogenesis by facilitating co‐transcriptional Drosha recruitment , 2012, The EMBO journal.

[42]  C. Perrone-Capano,et al.  Restriction of Neural Precursor Ability to Respond to Nurr1 by Early Regional Specification , 2012, PloS one.

[43]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[44]  Stephanie C Huelga,et al.  Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs , 2012, Nature Neuroscience.

[45]  T. Hortobágyi,et al.  Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion , 2012, Acta Neuropathologica.

[46]  D. Campion,et al.  Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila , 2012, Neurobiology of Aging.

[47]  S. Servidei,et al.  P525L FUS mutation is consistently associated with a severe form of juvenile Amyotrophic Lateral Sclerosis , 2012, Neuromuscular Disorders.

[48]  S. Petri,et al.  Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways , 2011, The Journal of experimental medicine.

[49]  N. Maragakis,et al.  Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo , 2011, Proceedings of the National Academy of Sciences.

[50]  J. Mendell,et al.  Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons , 2011, Nature Biotechnology.

[51]  M. Mesulam,et al.  Expression of human FUS protein in Drosophila leads to progressive neurodegeneration , 2011, Protein & Cell.

[52]  Daniel F Tardiff,et al.  A Yeast Model of FUS/TLS-Dependent Cytotoxicity , 2011, PLoS biology.

[53]  W. Robberecht,et al.  Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease , 2011, The Lancet Neurology.

[54]  Jane Y. Wu,et al.  Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy , 2011, Protein & Cell.

[55]  I. Mackenzie,et al.  TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.

[56]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[57]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[58]  K. Sleegers,et al.  Genetic contribution of FUS to frontotemporal lobar degeneration , 2010, Neurology.

[59]  Zachary D. Smith,et al.  Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses , 2009 .

[60]  Weihua Zhao,et al.  Microglia in ALS: The Good, The Bad, and The Resting , 2009, Journal of Neuroimmune Pharmacology.

[61]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[62]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[63]  R. Mantovani,et al.  The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-κB target genes by interaction with NFKBIZ , 2009, Oncogene.

[64]  E. Cacci,et al.  In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia , 2008, Glia.

[65]  D. Gutmann,et al.  Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.

[66]  M. Bonaguidi,et al.  LIF and BMP signaling generate separate and discrete types of GFAP-expressing cells , 2005, Development.

[67]  P. Moynagh.  The interleukin‐1 signalling pathway in astrocytes: a key contributor to inflammation in the brain , 2005, Journal of anatomy.

[68]  G. Pasinetti,et al.  A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  P. Mcgeer,et al.  Inflammatory processes in amyotrophic lateral sclerosis , 2002, Muscle & nerve.

[70]  R. McKay,et al.  Sequential actions of BMP receptors control neural precursor cell production and fate. , 2001, Genes & development.

[71]  M. Itoh,et al.  Involvement of the Pro-oncoprotein TLS (Translocated in Liposarcoma) in Nuclear Factor-κB p65-mediated Transcription as a Coactivator* , 2001, The Journal of Biological Chemistry.

[72]  J. Rothstein,et al.  Inhibition of cyclooxygenase‐2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis , 2000, Annals of neurology.

[73]  V. Perry,et al.  Increased Brain Synthesis of Prostaglandin E2 and F2‐Isoprostane in Human and Experimental Transmissible Spongiform Encephalopathies , 2000, Journal of neuropathology and experimental neurology.

[74]  E. Powell,et al.  Dissection of astrocyte‐mediated cues in neuronal guidance and process extension , 1999, Glia.

[75]  G. Levi,et al.  Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. , 1998, Biochimie.